Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label in the page footer updated from v3.6.5 to v3.6.6. This indicates a minor site version update and does not change the study details or functionality.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer published version of the page. No study text or behavior appears to have changed.SummaryDifference0.0%

- Check49 days agoChange DetectedA new site revision label v3.6.4 was added, replacing the previous v3.6.3. This reflects an updated build/version tag shown on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedA new publication citation is added to the Publications section for a prespecified secondary analysis from the SUMMIT trial. The entry describes Tirzepatide effects in obesity-related HFpEF by sex.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.6.3 now appears on the page, replacing the previous v3.6.2. This indicates a minor page update or QC change to the study listing rather than new study content.SummaryDifference0.0%

- Check78 days agoChange DetectedA new citation from Diabetes Obes Metab (2024) is added to the Publications section. The study record revision is updated from v3.6.0 to v3.6.2.SummaryDifference0.0%

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.